Should cancer survivors fear radiation-induced sarcomas?

Sarcoma

Volumn 1, Issue 1, 1997, Pages 5-15

  Feigen, Malcolm ^a  

^a AUSTIN HEALTH   (Australia)

Author keywords

Bone sarcoma; Radiation induced sarcoma; Soft tissue sarcoma

Indexed keywords

EID: 0042384325     PISSN: 1357714X     EISSN: None     Source Type: Journal    
DOI: 10.1080/13577149778425     Document Type: Review

References (96)

1. Frieben A. Cancroid des rechten Handrükens, das sich nach langdavernder Einwirkung von Roentgenstrahlen. Fortchr Röntgenstr 1902; 6:106.
2. Perthes G. Zur Frage der Röntgentherapie des Carcinoms. Arch Klin Chirurg 1904; 74:400-5.
3. Beck A. Zur frage des Röntgensarkoms, zugleich ein Beitrag zur Pathogenese des Sarkoms. München Medizin Wochenschr 1922; 69:623-4.
4. Martland HS. Occupational poisoning in manufacture of luminous watch dials. J Am Med Assoc 1929; 92:466-73.
5. Cahan WG, Woodard HQ, Higinbotham NL, et al. Sarcoma arising in irradiated bone. Report of eleven cases. Cancer 1948; 1:3-29.
6. Robinson E, Neugut AI, Wylie P. Clinical aspects of postirradiation sarcomas. J Natl Cancer Inst 1988; 80:233-40.
7. Wiklund TA, Blomqvist CP, Räty J, et al. Postirradiation sarcoma. Analysis of a nationwide cancer registry material. Cancer 1991; 68:524-31.
8. Tountas AA, Fornasier VL, Harwood AR, et al. Postirradiation sarcoma of bone. A perspective. Cancer 1979; 43:182-7.
9. Tucker MA, D'Angio GJ, Boice JD, et al. Bone sarcomas linked to radiotherapy and chemotherapy in children. N Engl J Med 1987; 317:588-93.
10. Harwood AR, Yaffe M. Cancer in man after diagnostic or therapeutic irradiation. Cancer Surv 1982; 1:703-31.
11. Phillips TL, Sheline GE. Bone sarcomas following radiation therapy. Radiology 1963; 81:992-6.
12. Ko JY, Chen CL, Lui LT, et al. Radiation-induced malignant fibrous histiocytoma in patients with nasopharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 1996; 122:535-8.
13. Hatlinghus S, Rode L, Christensen I et al. Sarcoma following irradiation for breast cancer. Report of three unusual cases including one malignant mesenchymoma of bone. Acta Radiol Oncol 1986; 25:239-42.
14. Brady MS, Gaynor JJ, Brennan MF. Radiation-associated sarcoma of bone and soft tissue. Arch Surg 1992; 127:1379-85.
15. Mark RJ, Poen J, Tran LM, et al. Postirradiation sarcomas. A single-institution study and review of the literature. Cancer 1994; 73:2653-62.
16. Abramson DH, Ellsworth RM, Kitchin D, et al. Second nonocular tumors in retinoblastoma survivors. Are they radiation-induced? Ophthalmology 1984; 91:1351-5.
17. Ducatman BS, Scheithauer BW. Postirradiation neurofibrosarcoma. Cancer 1983; 51:1028-33.
18. Garber JE, Goldstein AM, Kantor AF, et al. Follow-up study of twenty-four families with Li-Fraumeni syndrome. Cancer Res 1991; 51:6094-7.
19. Lavey RS, Eby NL, Prosnitz LR. Impact of second malignancy risk of the combined use of radiation and chemotherapy for lymphomas. Cancer 1990; 66:80-8.
20. Tarbell NJ, Gelber RD, Weinstein HJ, et al. Sex differences in risk of second malignant tumours after Hodgkin's disease in childhood. Lancet 1993; 341:1428-32.
21. Heyn R, Haeberlen V, Newton WA, et al. Second malignant neoplasms in children treated for rhabdomyosarcoma. J Clin Oncol 1993; 11:262-70.
22. Eng C, Li FP, Abramson DH, et al. Mortality from second tumors among long-term survivors of retinoblastoma. J Natl Cancer Inst 1993; 85: 1121-8.
23. Smith LM, Donaldson SS, Egbert PR, et al. Aggressive management of second primary tumors in survivors of hereditary retinoblastoma. Int J Radiat Oncol Biol Phys 1989; 17:499-505.
24. Plowman PN, Kingston JE, Hungerford JL. Prophylactic retinal radiotherapy has an exceptional place in the management of familial retinoblastoma. Br J Cancer 1993; 68:743-5.
25. Hatfield PM, Schulz MD. Postirradiation sarcoma. Including 5 cases after X-ray therapy of breast cancer. Radiology 1970; 96:593-602.
26. Ferguson DJ, Sutton HG, Dawson PJ. Late effects of adjuvant radiotherapy for breast cancer. Cancer 1984; 54:2319-23.
27. Kurtz JM, Amalric R, Brandone H, et al. Contralateral breast cancer and other second malignancies in patients treated by breast-conserving therapy with radiation. Int J Radiat Oncol Biol Phys 1988; 15:277-84.
28. Lavey RS, Eby NL, Prosnitz LR. Impact of radiation therapy and/or chemotherapy on the risk for a second malignancy after breast cancer. Cancer 1990; 66:874-81.
29. Taghian A, De Vathaire F, Terrier P, et al. Long-term risk of sarcoma following radiation treatment for breast cancer. Int J Radiat Oncol Biol Phys 1991; 21:361-7.
30. Pierce SM, Recht A, Lingos TI, et al. Long-term radiation complications following conservative surgery (CS) and radiation therapy (RT) in patients with early stage breast cancer. Int Radiat Oncol Biol Phys 1992; 23:915-23.
31. Doherty MA, Rodger A, Langlands AO, et al. Multiple primary tumours in patients treated with radiotherapy for breast cancer. Radiother Oncol 1993; 26:125-31.
32. Zucali R, Merson M, Placucci M, et al. Soft tissue sarcoma of the breast after conservative surgery and irradiation for early mammary cancer. Radiother Oncol 1994; 30:271-3.
33. Karlsson P, Holmberg E, Johansson KA, et al. Soft tissue sarcoma after treatment for breast cancer. Radiother Oncol 1996; 38:25-31.
34. Doherty MA, Rodger A, Langlands AO. Sarcoma of bone following therapeutic irradiation for breast carcinoma. Int J Radiat Oncol Biol Phys 1986; 12:103-6.
35. Mamounas EP, Perez-Mesa C, Penetrante RB, et al. Patterns of occurrence of second primary non-mammary malignancies in breast cancer patients: results from 1382 consecutive autopsies. Surg Oncol 1993; 2:175-85.
36. Bobin JY, Rivoire M, Delay E, et al. Radiation induced sarcomas following treatment for breast cancer: presentation of a series of 14 cases treated with an aggressive surgical approach. J Surg Oncol 1994; 57:171-7.
37. Cafiero F, Gipponi M, Peressini A, et al. Radiation-associated angiosarcoma. Diagnostic and therapeutic implications - two case reports and a review of the literature. Cancer 1996; 77:2496-502.
38. Lemson MS, Mud HJ, Wijnmaalen AJ, et al. Post-radiation fibrosarcoma of the breast. The Breast 1996; 5:368-71.
39. Kaldor JM, Day NE, Band P, et al. Second malignancies following testicular cancer, ovarian cancer and Hodgkin's disease: an international collaborative study among cancer registries. Int J Cancer 1987; 39:571-85.
40. Boivin JF, O'Brien K. Solid cancer risk after treatment of Hodgkin's disease. Cancer 1988; 61:2541-6.
41. Cimino G, Papa G, Tura S, et al. Second primary cancer following Hodgkin's disease: updated results of an Italian multicentric study. J Clin Oncol 1991; 9:432-7.
42. Henry-Amar M. Second cancer risk after the treatment for Hodgkin's disease: a report from the International Database on Hodgkin's Disease. Ann Oncol 1992; 3:8117-28.
43. Swerdlow AJ, Douglas AJ, Vaughan Hudson G, et al. Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation. Br Med J 1992; 304:1137-43.
44. Rodriguez MA, Fuller LM, Zimmerman SO, et al. Hodgkin's disease: study of treatment intensities and incidences of second malignancies. Ann Oncol 1993; 4:125-31.
45. Biti G, Cellai E, Magrini SM, et al. Second solid tumors and leukemia after treatment for Hodgkin's disease: an analysis of 1121 patients from a single institution. Int J Radiat Oncol Biol Phys 1994; 29:25-31.
46. Abrahamsen JF, Andersen A, Hannisdal E, et al. Second malignancies after treatment of Hodgkin's disease: the influence of treatment, follow-up time and age. J Clin Oncol 1993; 11:255-61.
47. van Leeuwen FE, Klokman WJ, Hagenbeek A, et al. Second cancer risk following Hodgkin's disease: a 20-year follow-up study. J Clin Oncol 1994; 12:312-25.
48. Boivin JF, Hutchison GB, Zauber AG, et al. Incidence of second cancers in patients treated for Hodgkin's disease. J Natl Cancer Inst 1995; 87:732-41.
49. Barton M, Boyages J, Crennan E, et al. Radiation therapy for early stage Hodgkin's disease: Australasian Patterns of Care. Int J Radiat Oncol Biol Phys 1995; 31:227-36.
50. Mauch PM, Kalish LA, Marcus KC, et al. Long-term survival in Hodgkin's disease. Relative impact of mortality, second tumors, infection, and cardiovascular disease. Cancer J Sci Am 1995; 1:33-42.
51. Beaty O, Hudson MM, Greenwald C, et al. Subsequent malignancies in children and adolescents after treatment for Hodgkin's disease. J Clin Oncol 1995; 13:603-9.
52. Bhatia S, Robison LL, Oberlin O, et al. Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med 1996; 334:745-51.
53. Sankila R, Garwicz S, Olsen JH, et al. Risk of subsequent malignant neoplasms among 1641 Hodgkin's disease patients diagnosed in childhood and adolescence: a population-based cohort study in the five Nordic countries. J Clin Oncol 1996; 14:1442-6.
54. Hay JH, Duncan W, Kerr GR. Subsequent malignancies in patients irradiated for testicular tumours. Br J Radiol 1984; 57:597-602.
55. Coleman MP, Bell CMJ, Fraser P. Second primary malignancy after Hodgkin's disease, ovarian cancer and cancer of the testis: a population-based cohort study. Br J Cancer 1987; 56:349-55.
56. Fossa SD, Langmark F, Aass N, Andersen A, et al. Second non-germ cell malignancies after radiotherapy of testicular cancer with or without chemotherapy. Br J Cancer 1990; 61:639-43.
57. Hanks GE, Peters T, Owen J. Seminoma of the testis: long term beneficial and deleterious results of radiation. Int J Radiat Oncol Biol Phys 1992; 24:913-19.
58. Jacobsen GK, Mellemgaard A, Engelholm SA, et al. Increased incidence of sarcoma in patients treated for testicular seminoma. Eur J Cancer 1993; 29A:664-8.
59. van Leeuwen FE, Stiggelbout AM, van den Belt-Dusebout AW, et al. Second cancer risk following testicular cancer: a follow-up study of 1909 patients. J Clin Oncol 1993; 11:415-24.
60. Bokemeyer C, Schmoll HJ. Secondary neoplasms following treatment of malignant germ cell tumors. J Clin Oncol 1993; 11:1703-9.
61. Dieckmann KP, Wegner HEH, Krain J. Multiple primary neoplasms in patients with testicular germ cell tumor. Oncology 1994; 51:450-8.
62. Travis LB, Curtis RE, Hankey BF. Correspondence: Second malignancies after testicular cancer. J Clin Oncol 1995; 13:533-4.
63. Bokemeyer C, Schmoll HJ. Treatment of testicular cancer and the development of secondary malignancies. J Clin Oncol 1995; 13:283-92.
64. Giwercman A, von der Maase H, Berthelsen JG, et al. Localized irradiation of testes with carcinoma in situ: effects on Leydig cell function and eradication of malignant germ cells in 20 patients. J Clin Endocrinol Metab 1991; 73:596-603.
65. Radford DM, Johnson FE, Janney CG. Sarcomatous change in a teratoma after treatment of testicular carcinoma. Cancer 1991; 68:395-9.
66. Lee KC, Yeung K, Welsh C, et al. Angiosarcoma following treatment of testicular seminoma: case report and literature review. J Urol 1995; 153:1055-6.
67. Jones A. Radiation oncogenesis in relation to the treatment of pituitary tumours. Clin Endocrinol 1991; 35:379-97.
68. Brada M, Ford D, Ashley S, et al. Risk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma. Br J Med 1992; 304: 1343-6.
69. Tsang RW, Laperriere NJ, Simpson WJ, et al. Glioma arising after radiation therapy for pituitary adenoma. A report of four patients and estimation of risk. Cancer 1993; 72:2227-33.
70. Hughes MH, Llamas KJ, Yelland ME, et al. Pituitary adenomas: long-term results for radiotherapy alone and post-operative radiotherapy. Int J Radiat Oncol Biol Phys 1993; 27:1035-43.
71. Bliss P, Kerr GR, Gregor A. Incidence of second brain tumours after pituitary irradiation in Edinburgh 1962-1990. Clin Oncol 1994; 6:361-3.
72. Seydel HG. The risk of tumor induction in man following medical irradiation for malignant neoplasm. Cancer 1975; 35:1641-5.
73. Brown M. Second primaries in cases of cancer of the larynx. J Laryngol Otol 1978; 92:991-6.
74. Sleeves RA, Bataini JP. Neoplasms induced by megavoltage radiation in the head and neck region. Cancer 1981; 47:1770-4.
75. Shibuya H, Hisamitsu S, Shioiri S, et al. Multiple primary cancer risk in patients with squamous cell cancer of the oral cavity. Cancer 1987; 60:3083-6.
76. Parker RG, Enstrom JE. Second primary cancers of the head and neck following treatment of initial primary head and neck cancers. Int J Radiat Oncol Biol Phys 1988; 14:561-4.
77. McDonald S, Haie C, Rubin P, et al. Second malignant tumors in patients with laryngeal carcinoma: diagnosis, treatment and prevention. Int J Radiat Oncol Biol Phys 1989; 17:457-65.
78. van der Laan BFAM, Baris G, Gregor RT, et al. Radiation-induced tumours of the head and neck. J Laryngol Otol 1995; 109:346-9.
79. Fein DA, Lee WR, Amos WR, et al. Oropharyngeal carcinoma treated with radiotherapy: a 30-year experience. Int J Radiat Oncol Biol Phys 1996; 34:289-96.
80. Wang CC, Hong JH, Hsu KH, et al. Second malignant tumors in Chinese patients with nasopharyngeal carcinoma following radiotherapy. Int J Radiat Oncol Biol Phys 1996; 36 Suppl:163 (abstract).
81. Parsons JT. The effect of radiation on normal tissues of the head and neck. In: Million RR, Cassisi NJ (eds). Management of head and neck cancer. A multidisciplinary approach, 2nd edn. Philadelphia: JB Lippincott, 1994:284.
82. Boice JD, Day NE, Andersen A, et al. Second cancers following radiation treatment for cervical cancer. An international collaboration among cancer registries. J Natl Cancer Inst 1985; 74:955-75.
83. Czesnin K, Wronkowski Z. Second malignancies in the irradiated area in patients treated for uterine cervix cancer. Gynecol Oncol 1978; 6:309-15.
84. Storm HH. Second primary cancer after treatment for cervical cancer. Late effects after radiotherapy. Cancer 1988; 61:679-88.
85. Arai T, Nakano T, Fukuhisa K, et al. Second cancer after radiation therapy for cancer of the uterine cervix. Cancer 1991; 67:398-405.
86. Kleinerman RA, Boice JD, Storm HH, et al. Second primary cancer after treatment for cervical cancer. An International Cancer Registries Study. Cancer 1995; 76:442-52.
87. Boice JD, Engholm G, Kleinerman RA, et al. Radiation dose and second cancer risk in patients treated for cancer of the cervix. Radia Res 1988; 116:3-55.
88. Chumas JC, Patsner B, Mann WJ. High-grade pelvic sarcoma after radiation therapy for low-grade endometrial stromal sarcoma. Gynecol Oncol 1990; 36:428-31.
89. Parkash V, Carcangiu ML. Uterine papillary serous carcinoma after radiation therapy for carcinoma of the cervix. Cancer 1992; 69:496-501.
90. Mettler FA, Upton AC. Carcinogenesis of specific organ sites. In: Medical effects of ionizing radiation, 2nd edn. Philadelphia: WB Saunders, 1995:164-6.
91. Hall EJ. Radiation carcinogenesis. In: Radiobiology for the radiologist, 4th edn. Philadelphia: JB Lippincott, 1994; 336.
92. Pedersen-Bjergaard J, Jonsson V, Pedersen M, et al. Correspondence. Leiomyosarcoma of the urinary bladder after cyclophosphamide. J Clin Oncol 1995; 13:532-3.
93. Makek MS, Andrews JC, Fisch U. Malignant transformation of a nasopharyngeal angiofibroma. Laryngoscope 1989; 99:1088-92.
94. Hefti FL, Gaechter A, Remagen W, et al. Recurrent giant-cell tumor with metaplasia and malignant change, not associated with radiotherapy. J Bone Joint Surg 1992; 74A:930-4.
95. Tharp ME, Shidnia H. Radiotherapy in the treatment of verrucous carcinoma of the head and neck. Laryngoscope 1995; 105:391-6.
96. Bloehle C, Peiper M, Schwarz R, et al. Postirradiation soft tissue sarcoma. Eur J Cancer 1995; 31A:31-4.